Cytek Biosciences Inc
F:8EQ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cytek Biosciences Inc
F:8EQ
|
US |
|
Trupanion Inc
NASDAQ:TRUP
|
US |
|
KULR Technology Group Inc
F:7FA0
|
US |
|
ICICI Securities Ltd
NSE:ISEC
|
IN |
|
Kofola CeskoSlovensko as
F:48K
|
CZ |
|
Parker-Hannifin Corp
NYSE:PH
|
US |
|
Electrocomponents PLC
F:ECN
|
UK |
|
Vale SA
BOVESPA:VALE3
|
BR |
|
T
|
Takeda Pharmaceutical Co Ltd
SWB:TKDA
|
JP |
|
C
|
China Lilang Ltd
F:5LX
|
CN |
|
A
|
Adidas AG
MIL:ADS
|
DE |
|
B
|
Brunello Cucinelli SpA
XMUN:8BU
|
IT |
|
L
|
Liveramp Holdings Inc
SWB:XIM
|
US |
|
T
|
Thai Stanley Electric PCL
SET:STANLY
|
TH |
|
Guangdong Investment Ltd
HKEX:270
|
HK |
|
Essential Utilities Inc
NYSE:WTRG
|
US |
|
Cohen & Steers Inc
NYSE:CNS
|
US |
|
B
|
Bank CIMB Niaga Tbk PT
XMUN:NKX
|
ID |
Bankruptcy Probability
Cytek Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cytek Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cytek Biosciences Inc
NASDAQ:CTKB
|
556.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
214.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
137.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
383.2B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
39.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
68.7T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
39.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
39.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Waters Corp
NYSE:WAT
|
37.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Illumina Inc
NASDAQ:ILMN
|
31B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cytek Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cytek Biosciences Inc has total debt of 386k USD. This includes both short-term (0 USD) and long-term (386k USD) debt.
You can find a full breakdown on its Balance Sheet.